Dr. Andrea Burnett-Hartman of the Public Health Sciences Division has been selected as one of 30 Women in Cancer Research scholars by the American Association for Cancer Research. The award provides a travel stipend for Burnett-Hartman to attend AACR's annual meeting in Chicago, March 31-April 4, where she will present colorectal cancer research findings.
Burnett-Hartman, who works as a postdoctoral research associate with Dr. Polly Newcomb, conducts research on colorectal cancer precursor lesions. She and her team found that a class of serrated colorectal polyps may be important precursors for the subset of colorectal cancer exhibiting BRAF gene mutation.
Founded in 1907, AACR is the world's first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR's membership includes 34,000 laboratory, translational and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. Merck Oncology and the William H. Pruscoff Foundation provided additional funding for the awardees.